Hillrom and Welch Allyn are a part of Baxter.
text.skipToContent text.skipToNavigation
  1. Baxter Catalog
  2. Pharmaceuticals
  3. Premixed Medications
  4. Milrinone Lactate in 5% Dextrose Injection, 40 mg/200 mL (200 mcg/mL) INTRAVIA Plastic Container. Liquid Premix.
Due to missing information on your Hillrom Direct account, you are not able to add items to the cart or continue with the checkout process. Please contact our customer support team for further assistance by clicking on "contact us".
MP_logo
Milrinone Lactate in 5% Dextrose Injection, 40 mg/200 mL (200 mcg/mL) INTRAVIA Plastic Container. Liquid Premix.
Item Number: 2J0901
GTIN:  0303386011371
GTIN-CS:  50300338601135
Milrinone Lactate in 5% in Dextrose Injection, 40 mg/200 mL (200 mcg/mL) in INTRAVIA Plastic Container. Liquid Premix. NDC 0338-6011-37
print-icon Print email-icon Email
Email PDF ✕
Specifications

Product Characteristics

Minimum Storage Temperature -99.0 °C
Maximum Storage Temperature 99.0 °C
Volume 200.0 cf
DEHP Free No
PVC Free No
Latex Free No
Shelf Life from Manufacture 0
Concentration 200 mcg/mL
Container Type INTRAVIA
Containes Preservative No
Diluent Dextrose
Dosage Form Liquid
Drug Class Vasodilator
Rx Only Yes
Storage Recommendations Store at room temperature 25°C (77°F), brief exposure up to 40° C (104° F) does not adversely affect the product.
Strength 40 mg/200 mL

Carton

Units per Case 10.0
Carton Weight 6.35 lb.
Carton Length 13.6 in.
Carton Width 12.7 in.
Carton Height 5.0 in.
Carton Volume 0.5 fc

Reimbursement Information

HCPCS Code HCPCS Description
A4216 STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML
J2260 INJECTION, MILRINONE LACTATE, 5 MG
Medication Delivery Reimbursement Hotline 888-338-0001

Information Source : CMS

Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Ordering Information
Item Number 2J0901
Sales Unit case
GTIN 0303386011371
GTIN-CS 50300338601135
National Drug Code 00338601137